Voice/Vocal Biomarker Market - A Global and Regional Analysis
Published Year: 2025
The global voice/vocal biomarker market is projected to reach $5,397.7 million by 2035 from $1,081.3 million in 2024, growing at a CAGR of 15.81% during the forecast period 2025-2035.
$4900
Primary Highlights Of The Report
Voice/Vocal Biomarker Market Report Coverage
How can this report add value to an organization?
Global Voice/Vocal Biomarker Market Industry Overview
Table of Contents
1 Global Voice/Vocal Biomarker Market: Industry Outlook
1.1 Industry Outlook
1.1.1 Market Overview and Ecosystem
1.1.1.1 Future Direction and Emerging Technology
1.1.2 Competitive Assessment
1.1.2.1 Go-to-Market Strategy
1.1.2.2 Competitive Landscape
1.1.2.2.1 Business Strategies
1.1.3 Opportunity Assessment
1.1.3.1 Strategic Opportunities of Stakeholders in Voice/Vocal Biomarker Market
1.1.3.2 Market Opportunity and Demand Analysis
1.1.4 Funding Analysis
1.2 Market Dynamics
1.2.1 Trends, Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
1.3 Trends
1.3.1 Integration of AI/ML into Vocal Biomarker Technologies
1.3.2 Market Drivers
1.3.2.1 Rising Application of Vocal Biomarkers as Novel Diagnostic and Monitoring Aid
1.3.2.2 Increasing Demand for Remote and Non-Invasive Health Monitoring
1.3.2.3 Adoption of Vocal Biomarkers in Health and Wellness Apps
1.3.3 Market Restraints
1.3.3.1 Regulatory Challenges and Unclear Guidelines
1.3.3.1.1 Regulatory Approval for AI/ML-based Vocal Biomarker Applications
1.3.3.1.2 Need for Clinical Validation
1.3.3.2 Integration of Vocal Biomarker Technologies in Healthcare Systems and Associated Complexities
1.3.3.2.1 Integration with EHR
1.3.3.2.2 Integration with Telehealth Platforms
1.3.3.2.3 Integration with Wearables and Smart Devices
1.3.4 Market Opportunities
1.3.4.1 Early Disease Detection and Prevention using Vocal Biomarkers
1.3.4.2 Increasing Number of Clinical Trials and Research on Vocal Biomarker
1.3.5 Market Challenges
1.3.5.1 Technology Limitations and Accuracy Issues
1.3.5.2 Lack of Standardized Regulations on Vocal Biomarker
2 Platform Type
2.1 Overview
2.2 Growth Share Matrix
2.2.1 Cloud-Based Platform
2.3 Web-Based Platform
3 Application Type
3.1 Overview
3.2 Growth Share Matrix
3.2.1 Monitoring
3.2.2 Diagnostics
3.2.3 Clinical Research
3.2.4 Others
4 Indication
4.1 Overview
4.2 Growth Share Matrix
4.2.1 Mental Health Disorder
4.2.2 Neurological Disorder
4.2.3 Respiratory Diseases
4.2.4 Cardiovascular Diseases
4.2.5 Others
5 End User
5.1 Overview
5.2 Growth Share Matrix
5.2.1 Hospitals
5.2.2 CROs
5.2.3 Research Institutions
6 Region
6.1 North America
6.1.1 Regional Overview
6.1.2 Driving Factors for Market Growth
6.1.3 Factors Challenging the Market
6.1.4 Market Sizing and Forecast
6.1.4.1 North America Voice/Vocal Biomarkers Market, by Platform Type
6.1.4.2 North America Voice/Vocal Biomarkers Market, by Application
6.1.4.3 North America Voice/Vocal Biomarkers Market, by Indication
6.1.4.4 North America Voice/Vocal Biomarkers Market, by End User
6.1.4.5 North America Voice/Vocal Biomarkers Market, by Country
6.1.5 U.S.
6.1.5.1 Country Overview
6.1.5.1.1 Market Sizing and Forecast
6.1.6 Canada
6.1.6.1 Country Overview
6.1.6.1.1 Market Sizing and Forecast
6.2 Europe
6.2.1 Regional Overview
6.2.2 Driving Factors for Market Growth
6.2.3 Factors Challenging the Market
6.2.4 Market Sizing and Forecast
6.2.4.1 Europe Voice/Vocal Biomarkers Market, by Platform Type
6.2.4.2 Europe Voice/Vocal Biomarkers Market, by Application
6.2.4.3 Europe Voice/Vocal Biomarkers Market, by Indication
6.2.4.4 Europe Voice/Vocal Biomarkers Market, by End User
6.2.4.5 Europe Voice/Vocal Biomarkers Market, by Country
6.2.5 U.K.
6.2.5.1 Country Overview
6.2.5.1.1 Market Sizing and Forecast
6.2.6 Germany
6.2.6.1 Country Overview
6.2.6.1.1 Market Sizing and Forecast
6.2.7 France
6.2.7.1 Country Overview
6.2.7.1.1 Market Sizing and Forecast
6.2.8 Italy
6.2.8.1 Country Overview
6.2.8.1.1 Market Sizing and Forecast
6.2.9 Spain
6.2.9.1 Country Overview
6.2.9.1.1 Market Sizing and Forecast
6.2.10 Rest-of-the- Europe
6.2.10.1 Country Overview
6.2.10.1.1 Market Sizing and Forecast
6.3 Asia-Pacific
6.3.1 Regional Overview
6.3.2 Driving Factors for Market Growth
6.3.3 Factors Challenging the Market
6.3.4 Market Sizing and Forecast
6.3.4.1 Asia-Pacific Voice/Vocal Biomarkers Market, by Platform Type
6.3.4.2 Asia-Pacific Voice/Vocal Biomarkers Market, by Application
6.3.4.3 Asia-Pacific Voice/Vocal Biomarkers Market, by Indication
6.3.4.4 Asia-Pacific Voice/Vocal Biomarkers Market, by End User
6.3.4.5 Asia-Pacific Voice/Vocal Biomarkers Market, by Country
6.3.5 China
6.3.5.1 Country Overview
6.3.5.1.1 Market Sizing and Forecast
6.3.6 Japan
6.3.6.1 Country Overview
6.3.6.1.1 Market Sizing and Forecast
6.3.7 India
6.3.7.1 Country Overview
6.3.7.1.1 Market Sizing and Forecast
6.3.8 Australia
6.3.8.1 Country Overview
6.3.8.1.1 Market Sizing and Forecast
6.3.9 South Korea
6.3.9.1 Country Overview
6.3.9.1.1 Market Sizing and Forecast
6.3.10 Rest-of-the- Asia-Pacific
6.3.10.1 Country Overview
6.3.10.1.1 Market Sizing and Forecast
6.4 Latin America
6.4.1 Regional Overview
6.4.2 Driving Factors for Market Growth
6.4.3 Factors Challenging the Market
6.4.4 Market Sizing and Forecast
6.4.4.1 Latin America Voice/Vocal Biomarkers Market, by Platform Type
6.4.4.2 Latin America Voice/Vocal Biomarkers Market, by Application
6.4.4.3 Latin America Voice/Vocal Biomarkers Market, by Indication
6.4.4.4 Latin America Voice/Vocal Biomarkers Market, by End User
6.5 Middle East and Africa
6.5.1 Regional Overview
6.5.2 Driving Factors for Market Growth
6.5.3 Factors Challenging the Market
6.5.4 Market Sizing and Forecast
6.5.4.1 Middle East and Africa Voice/Vocal Biomarkers Market, by Platform Type
6.5.4.2 Middle East and Africa Voice/Vocal Biomarkers Market, by Application
6.5.4.3 Middle East and Africa Voice/Vocal Biomarkers Market, by Indication
6.5.4.4 Middle East and Africa Voice/Vocal Biomarkers Market, by End User
7 Competitive Landscape and Company Profiles
7.1 Company Position Analysis in Voice/Vocal Biomarkers Market
7.2 Company Profiles
7.2.1 audEERING GmbH
7.2.1.1 Overview
7.2.1.2 Top Competitors and Target Customers
7.2.1.3. Product Offerings
7.2.1.3 Strategic Positioning and Research Initiatives
7.2.1.4 Analyst View
7.2.2 Biosensics
7.2.2.1 Overview
7.2.2.2 Top Competitors and Target Customers
7.2.2.3. Product Offerings
7.2.2.3 Strategic Positioning and Research Initiatives
7.2.2.4 Analyst View
7.2.3 Canary Speech, Inc.
7.2.3.1 Overview
7.2.3.2 Top Competitors and Target Customers
7.2.3.3. Product Offerings
7.2.3.3 Strategic Positioning and Research Initiatives
7.2.3.4 Analyst View
7.2.4 Evocal Health GmbH.
7.2.4.1 Overview
7.2.4.2 Top Competitors and Target Customers
7.2.4.3. Product Offerings
7.2.4.3 Strategic Positioning and Research Initiatives
7.2.4.4 Analyst View
7.2.5 Kintsugi Mindful Wellness, Inc...
7.2.5.1 Overview
7.2.5.2 Top Competitors and Target Customers
7.2.5.3. Product Offerings
7.2.5.3 Strategic Positioning and Research Initiatives
7.2.5.4 Analyst View
7.2.6 PST Inc.
7.2.6.1 Overview
7.2.6.2 Top Competitors and Target Customers
7.2.5.3. Product Offerings
7.2.5.3 Strategic Positioning and Research Initiatives
7.2.5.4 Analyst View
7.2.7 Sonde Health
7.2.7.1 Overview
7.2.7.2 Top Competitors and Target Customers
7.2.7.3. Product Offerings
7.2.7.3 Strategic Positioning and Research Initiatives
7.2.7.4 Analyst View
7.2.8 Sound Health
7.2.8.1 Overview
7.2.8.2 Top Competitors and Target Customers
7.2.8.3. Product Offerings
7.2.8.4 Strategic Positioning and Research Initiatives
7.2.8.5 Analyst View
7.2.9 VoiceMed Italia srl
7.2.9.1 Overview
7.2.9.2 Top Competitors and Target Customers
7.2.9.3. Product Offerings
7.2.9.4 Strategic Positioning and Research Initiatives
7.2.9.5 Analyst View
7.2.10 Zana Technologies GmbH
7.2.10.1 Overview
7.2.10.2 Top Competitors and Target Customers
7.2.10.3. Product Offerings
7.2.10.4 Strategic Positioning and Research Initiatives
7.2.10.5 Analyst View
8 Research Methodology
8.1 Data Sources
8.1.1 Primary Data Sources
8.1.2 Secondary Data Sources
8.1.3 Inclusion and Exclusion
8.1.4 Data Triangulation
8.2 Market Estimation and Forecast
List of Tables
Table 1: Market Snapshot
Table 2: Recent Funding in Global Voice/Vocal Biomarker Market
Table 3: Use of AI/ML Technology by Companies
Table 4: Key Market Players and their Major Contributions
Table 5: Few Clinical Trials Related to Voice Biomarker
Table 6: Companies using Platform for Voice/Vocal Biomarker
Table 7: Global Voice/Vocal Biomarkers Market (by Region), $Million, 2024-2035
Table 8: North America Voice/Vocal Biomarkers Market (by Platform Type), $Million, 2024-2035
Table 9: North America Voice/Vocal Biomarkers Market (by Application), $Million, 2024-2035
Table 10: North America Voice/Vocal Biomarkers Market (by Indication), $Million, 2024-2035
Table 11: North America Voice/Vocal Biomarkers Market (by End User), $Million, 2024-2035
Table 12: North America Voice/Vocal Biomarkers Market (by Country), $Million, 2024-2035
Table 13: Europe Voice/Vocal Biomarkers Market (by Platform Type), $Million, 2024-2035
Table 14: Europe Voice/Vocal Biomarkers Market (by Application), $Million, 2024-2035
Table 15: Europe Voice/Vocal Biomarkers Market (by Indication), $Million, 2024-2035
Table 16: Europe Voice/Vocal Biomarkers Market (by End User), $Million, 2024-2035
Table 17: Europe Voice/Vocal Biomarkers Market (by Country), $Million, 2024-2035
Table 18: Asia-Pacific Voice/Vocal Biomarkers Market (by Platform Type), $Million, 2024-2035
Table 19: Asia-Pacific Voice/Vocal Biomarkers Market (by Application), $Million, 2024-2035
Table 20: Asia-Pacific Voice/Vocal Biomarkers Market (by Indication), $Million, 2024-2035
Table 21: Asia-Pacific Voice/Vocal Biomarkers Market (by End User), $Million, 2024-2035
Table 22: Asia-Pacific Voice/Vocal Biomarkers Market (by Country), $Million, 2024-2035
Table 23: Latin America Voice/Vocal Biomarkers Market (by Platform Type), $Million, 2024-2035
Table 24: Latin America Voice/Vocal Biomarkers Market (by Application), $Million, 2024-2035
Table 25: Latin America Voice/Vocal Biomarkers Market (by Indication), $Million, 2024-2035
Table 26: Latin America Voice/Vocal Biomarkers Market (by End User), $Million, 2024-2035
Table 27: Middle East and Africa Voice/Vocal Biomarkers Market (by Platform Type), $Million, 2024-2035
Table 28: Middle East and Africa Voice/Vocal Biomarkers Market (by Application), $Million, 2024-2035
Table 29: Middle East and Africa Voice/Vocal Biomarkers Market (by Indication), $Million, 2024-2035
Table 30: Middle East and Africa Voice/Vocal Biomarkers Market (by End User), $Million, 2024-2035
List of Figures
Figure 1: Voice/Vocal Biomarker Market (by Scenario), $Million, 2024, 2028, and 2035
Figure 2: Global Voice/Vocal Biomarker Market, 2024-2035
Figure 3: Top 10 Countries, Global Voice/Vocal Biomarker Market, $Million, 2024
Figure 4: Global Voice/Vocal Biomarker Market Snapshot
Figure 5: Global Voice/Vocal Biomarker Market, $Million, 2024 and 2035
Figure 6: Voice/Vocal Biomarker Market (by Platform Type), $Million, 2024, 2028, and 2035
Figure 7: Voice/Vocal Biomarker Market (by Application Type), $Million, 2024, 2028, and 2035
Figure 8: Voice/Vocal Biomarker Market (by Indication Type), $Million, 2024, 2028, and 2035
Figure 9: Voice/Vocal Biomarker Market (by End User), $Million, 2024, 2028, and 2035
Figure 10: Voice/Vocal Biomarker Market Segmentation
Figure 11: Go-to-Market Strategy of Major Players
Figure 12: Go-to-Market Strategy of Major Players
Figure 13: Go-to-Market Strategy of Major Players
Figure 14: Companies Offering AI-based Vocal Biomarkers for Early Disease Detection
Figure 15: Global Voice/Vocal Biomarkers Market, by Platform Type, $Million, 2024, 2028, and 2035
Figure 16: Key Value Propositions of Cloud-Based Vocal Biomarker Platforms
Figure 17: Cloud-based Voice/Vocal Biomarkers Market, $Million, 2024-2035
Figure 18: Web-Based Voice/Vocal Biomarkers Market, $Million, 2024-2035
Figure 19: Global Voice/Vocal Biomarker Market, by Patient Type, $Million, 2024, 2028, and 2035
Figure 20: Global Voice/Vocal Biomarker Market, by Monitoring, $Million, 2024-2035
Figure 21: Global Voice/Vocal Biomarker Market, by Diagnostics, $Million, 2024-2035
Figure 22: Global Voice/Vocal Biomarker Market, by Clinical Research, $Million, 2024-2035
Figure 23: Global Voice/Vocal Biomarker Market, by Others, $Million, 2024-2035
Figure 24: Global Voice/Vocal Biomarker Market, by Indication, $Million, 2024, 2028, and 2035
Figure 25: Global Voice/Vocal Biomarker Market, by Mental Health Disorder, $Million, 2024-2035
Figure 26: Global Voice/Vocal Biomarker Market, by Neurological Disorder, $Million, 2024-2035
Figure 27: Global Voice/Vocal Biomarker Market, by Respiratory Diseases, $Million, 2024-2035
Figure 28: Global Voice/Vocal Biomarker Market, by Cardiovascular Diseases, $Million, 2024-2035
Figure 29: Global Voice/Vocal Biomarker Market, by Others, $Million, 2024-2035
Figure 30: Global Voice/Vocal Biomarker Market, by End User, $Million, 2024, 2028, and 2035
Figure 31: Global Voice/Vocal Biomarker Market, by Hospitals, $Million, 2024-2035
Figure 32: Global Voice/Vocal Biomarker Market, by CROs, $Million, 2024-2035
Figure 33: Global Voice/Vocal Biomarker Market, by Research Institutions, $Million, 2024-2035
Figure 34: North America Voice/Vocal Biomarkers Market, $Million, 2024-2035
Figure 35: U.S. Voice/Vocal BIomarkers Market, $Million, 2024-2035
Figure 36: Canada Voice/Vocal BIomarkers Market, $Million, 2024-2035
Figure 37: Europe Voice/Vocal Biomarkers Market, $Million, 2024-2035
Figure 38: U.K. Voice/Vocal BIomarkers Market, $Million, 2024-2035
Figure 39: Germany Voice/Vocal BIomarkers Market, $Million, 2024-2035
Figure 40: France Voice/Vocal BIomarkers Market, $Million, 2024-2035
Figure 41: Italy Voice/Vocal BIomarkers Market, $Million, 2024-2035
Figure 42: Spain Voice/Vocal BIomarkers Market, $Million, 2024-2035
Figure 43: Rest-of-the Europe Voice/Vocal BIomarkers Market, $Million, 2024-2035
Figure 44: Asia Pacific Voice/Vocal Biomarkers Market, $Million, 2024-2035
Figure 45: China Voice/Vocal BIomarkers Market, $Million, 2024-2035
Figure 46: Japan Voice/Vocal BIomarkers Market, $Million, 2024-2035
Figure 47: India Voice/Vocal BIomarkers Market, $Million, 2024-2035
Figure 48: Australia Voice/Vocal BIomarkers Market, $Million, 2024-2035
Figure 49: South-Korea Voice/Vocal BIomarkers Market, $Million, 2024-2035
Figure 50: Rest-of-the Asia-Pacific Voice/Vocal BIomarkers Market, $Million, 2024-2035
Figure 51: Latin America Voice/Vocal Biomarkers Market, $Million, 2024-2035
Figure 52: Middle East and Africa Voice/Vocal Biomarkers Market, $Million, 2024-2035
Figure 53: Inclusion and Exclusion Criteria for Global Voice/Vocal Biomarker Market
Figure 54: Data Triangulation
Figure 55: Top-Down and Bottom-Up Approach
Figure 56: Assumptions and Limitations
